Gut lumen small-molecule toxins and drugs

Gut lumen small-molecule toxins and drugs represent a heterogeneous group of low-molecular-weight substances found within the gastrointestinal tract that serve as the primary targets for non-systemically absorbed therapeutic agents. This category includes metabolic byproducts such as uremic toxins (e.g., indoxyl sulfate), excess dietary electrolytes like phosphate and potassium, and exogenous compounds such as ingested poisons or pharmaceutical overdoses (PMID: 31034075). Unlike traditional protein targets such as receptors or enzymes, these molecules are neutralized through physical or chemical sequestration, including adsorption onto porous surfaces or ion exchange within polymeric frameworks (PMID: 29243011). This therapeutic strategy is essential for managing chronic kidney disease (CKD) by reducing the systemic accumulation of uremic waste and for treating acute intoxications in emergency medicine (StatPearls: Activated Charcoal). By capturing these substances in the gut, drugs prevent their entry into the bloodstream or interrupt their enterohepatic circulation, thereby facilitating their removal from the body via fecal excretion. The clinical efficacy of targeting these molecules is typically monitored through serum levels of the specific toxins or electrolytes, and a major therapeutic challenge involves maintaining selectivity to avoid the depletion of essential nutrients or the binding of other necessary medications.

Other names

Intestinal toxinsLuminal small moleculesEnteric toxinsGastrointestinal toxinsUremic toxins (gut lumen)Ingested poisons

Non-systemic sequestration via physical adsorption, ion exchange, or chemical chelation within the gastrointestinal lumen to prevent systemic absorption or enhance fecal excretion (PMID: 29243011, StatPearls: Activated Charcoal).